GSK’s Tafinlar named as FDA breakthrough therapy for lung cancer

GSK’s Tafinlar named as FDA breakthrough therapy for lung cancer

The logo of GlaxoSmithKline (GSK) is seen on its office building in Shanghai July 12, 2013.

Credit: Reuters/Aly Song

Read the original here:
feeds.reuters

Healthy Living News From around The Web
GSK’s Tafinlar Named As FDA Breakthrough Therapy For Lung Cancer – Fox Business

Google+

Dopps Chiropractic
4746 S. Broadway
WichitaKs 67216

(316) 522-1122
http://DoppsChiropracticSouth.com

Leave a comment